Sort
17,828 grants matching “crispr”
Integrative transcriptional and epigenomic modeling of xenobiotic-activated gene regulatory networks
$477,403Sudin Bhattacharya · Michigan State University · R01 · FY2021 · ES
Liver-directed somatic gene correction rAAV system of regulatable Cas9/sgRNA
$477,375Wen Xue · Univ Of Massachusetts Med Sch Worcester · P01 · FY2017 · HL
Liver-directed somatic gene correction rAAV system of regulatable Cas9/sgRNA
$477,375Wen Xue · Univ Of Massachusetts Med Sch Worcester · P01 · FY2018 · HL
Mosquito hydration status as a mechanism that alters pre-feeding host interactions and post-feeding physiology
$477,121Josh B. Benoit · University Of Cincinnati · R01 · FY2024 · AI
Molecular Mechanisms underlying tRNA-fragment regulation of cancer
$477,012Sohail F. Tavazoie · Rockefeller University · R01 · FY2017 · CA
Curing Sickle Cell Disease with CRISPR-Cas9 genome editing
$476,994Mark C Walters · University Of California, San Francisco · OT2 · FY2020 · HL
Trophoblast development and placental susceptibility to cytomegalovirus infection
$476,771Craig John Bierle · University Of Minnesota · R01 · FY2023 · HD
Genomic analysis of microphthalmia, anophthalmia and coloboma
$476,732Anne M. Slavotinek · University Of California, San Francisco · R01 · FY2021 · EY
New Targets for Reproductive Control of Mosquito Vectors
$476,668Laura C Harrington · Cornell University · R01 · FY2019 · AI
Targeting CEBPA To Restore Epithelial-Mesenchymal Homeostasis In Lung Fibrosis
$476,658Qi Tan · Mayo Clinic Rochester · R01 · FY2020 · HL
NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer
$476,566Dan Theodorescu · Cedars-Sinai Medical Center · R01 · FY2024 · CA
The role of translation initiation factor eIF5B in lung cancer pathogenesis
$476,420Kathryn Ann O'Donnell · Ut Southwestern Medical Center · R01 · FY2025 · CA
The role of translation initiation factor eIF5B in lung cancer pathogenesis
$476,420Kathryn Ann O'Donnell · Ut Southwestern Medical Center · R01 · FY2023 · CA
Linking substance use genetics to circadian function using high-throughput genomics
$476,123Andreas Robert Pfenning · Carnegie-Mellon University · R01 · FY2025 · DA
Pharmaceutical Sciences and Pharmacogenomics
$476,062Nadav Ahituv · University Of California, San Francisco · T32 · FY2022 · GM
Traumatic Axonopathy in the CNS as Wallerian degeneration
$475,972Vassilis E Koliatsos · Johns Hopkins University · R01 · FY2021 · NS
Traumatic Axonopathy in the CNS as Wallerian degeneration
$475,972Vassilis E Koliatsos · Johns Hopkins University · R01 · FY2025 · NS
Traumatic Axonopathy in the CNS as Wallerian degeneration
$475,972Vassilis E Koliatsos · Johns Hopkins University · R01 · FY2023 · NS
Traumatic Axonopathy in the CNS as Wallerian degeneration
$475,972Vassilis E Koliatsos · Johns Hopkins University · R01 · FY2022 · NS
Organizational principles and functional role of 3D enhancer hubs in cell fate decisions
$475,955Effie Apostolou · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · GM
Targeting RNA Splicing in Glioma
$475,851Shi-Yuan Cheng · Northwestern University At Chicago · R01 · FY2024 · NS
Huntington's disease gene chromatin structure and modifiers
$475,840Vanessa C Wheeler · Massachusetts General Hospital · R21 · FY2019 · NS
Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits
$475,839Eugene Yu · Roswell Park Cancer Institute Corp · R01 · FY2022 · HD
Mechanisms of Revertant Mosaicism in Ichthyosis with Confetti
$475,832Keith A Choate · Yale University · R01 · FY2019 · AR
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
$475,682Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2022 · CA